CDC identifies next priority groups for COVID-19 vaccine
December 21, 2020
ACIP said the next priority group, Phase 1b, should consist of what it called frontline essential workers, a group of about 30 million, and adults aged 75 years and older, a group of about 21 million.
Second COVID-19 vaccine ready for use, CDC panel says
December 20, 2020
Moderna’s COVID-19 vaccine — the second now cleared for emergency use in the United States — was endorsed by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) on Dece...
FDA grants emergency use for Moderna COVID-19 vaccine
December 19, 2020
“It’s incumbent upon all us healthcare professionals to put ourselves out there as supporting this vaccine and supporting people getting it.”
Moderna COVID-19 vaccine wins decisive recommendation from FDA panel
December 18, 2020
The advisers and FDA staff also honed in on several key issues with COVID-19 vaccines, including the challenge of having people in the placebo groups of studies seek to get cleared vaccines.
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
Coronavirus has infected over 2% of U.S. children
December 15, 2020
AAP president: “In many areas, our health care system is terribly overburdened. The vaccine will not solve this overnight.”
Understanding messenger RNA and other SARS-CoV-2 vaccines
December 14, 2020
Technological advances make these new and revolutionary vaccines a reality.
CDC panel recommends Pfizer’s COVID-19 vaccine for people 16 and over
December 13, 2020
ACIP panelists said clinicians need more guidance on whether to use the vaccine in pregnant or breastfeeding women.
FDA OKs emergency use of Pfizer COVID-19 vaccine
December 12, 2020
“Vaccinating healthcare workers, in particular, will be a model for the general public.”
COVID-19 vaccines: Preparing for patient questions
December 11, 2020
Two experts discuss what clinicians can expect and what evidence-based – as well as compassionate – answers might look like.